ADVERSE REACTIONS
The major hazards of DILAUDID ORAL LIQUID and DILAUDID 8 mg TABLETS include respiratory depression and apnea. To a lesser degree, circulatory depression, respiratory arrest, shock and cardiac arrest have occurred.
The most frequently observed adverse effects are light-headedness, dizziness, sedation, nausea, vomiting, sweating, flushing, dysphoria, euphoria, dry mouth, and pruritus. These effects seem to be more prominent in ambulatory patients and in those not experiencing severe pain.
Less Frequently Observed Adverse Reactions
General and CNS
Weakness, headache, agitation, tremor, uncoordinated muscle movements, alterations of mood (nervousness, apprehension, depression, floating feelings, dreams), muscle rigidity, paresthesia, muscle tremor, blurred vision, nystagmus, diplopia and miosis, transient hallucinations and disorientation, visual disturbances, insomnia, increased intracranial pressure
Cardiovascular
Flushing of the face, chills, tachycardia, bradycardia, palpitation, faintness, syncope, hypotension, hypertension
Respiratory
Bronchospasm and laryngospasm
Gastrointestinal
Constipation, biliary tract spasm, ileus, anorexia, diarrhea, cramps, taste alteration
Genitourinary
Urinary retention or hesitancy, antidiuretic effects
Dermatologic
Urticaria, other skin rashes, diaphoresis
|
REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO DILAUDID
Below is a sample of reports where side effects / adverse reactions may be related to Dilaudid. The information is not vetted and should not be cosidered as verified clinical evidence.
Possible Dilaudid side effects / adverse reactions in 67 year old male
Reported by a pharmacist from Canada on 2007-01-26
Patient: 67 year old male
Reactions: Prostatic Specific Antigen Increased, Stomatitis, Metastases TO Liver, Disorientation, Asthenia, Metastases TO Bone, Brain Scan Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Lupron Depot-3
Dosage: 22.5 mg, 1 in 3 m, intramuscular
Indication: Prostate Cancer
Start date: 2006-07-04
Dilaudid
Dosage: unk., per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Fentanyl
Dosage: transdermal
Indication: Drug USE FOR Unknown Indication
Unspecified Norcotic
Dosage: unk., per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Possible Dilaudid side effects / adverse reactions in 47 year old female
Reported by a pharmacist from United States on 2007-01-31
Patient: 47 year old female
Reactions: Cyanosis, Depressed Level of Consciousness, Oxygen Saturation Decreased
Adverse event resulted in: life threatening event
Suspect drug(s):
Dilaudid
Other drugs received by patient: Buspar; Trazodone HCL; Singulair; Inderal; Albuterol; Lopid; Vytorin; Protonix; Zofran; Imitrex; Phenergan; Senokot; Benadryl
Possible Dilaudid side effects / adverse reactions in 40 year old male
Reported by a pharmacist from United States on 2007-01-31
Patient: 40 year old male weighing 56.0 kg (123.2 pounds)
Reactions: Rash
Suspect drug(s):
Dilaudid
Other drugs received by patient: Lactobacillus; Protonix; Risperdal; Zosyn; Zithromaxx; Tobramycin
|
